Clinical trials
Phase 3 Thromboembolism trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 3 |
| 2008 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2016 | 2 |
| 2019 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 6 |
| Bayer | 3 |
| Janssen Research & Development, LLC | 2 |
| AstraZeneca | 1 |
| Daiichi Sankyo | 1 |
| Population Health Research Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thromboembolism | 14 |
| Thrombosis | 3 |
| Venous Thromboembolism | 3 |
| Pulmonary Embolism | 2 |
| Stroke | 2 |
| Venous Thrombosis | 2 |
| Atrial Fibrillation | 1 |
| Communicable Diseases | 1 |
| Heart Failure | 1 |
| Hemorrhage | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.